Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Medical Writing/Editorial Assistance The authors acknowledge Alice Knapton, PhD, Noa Chapman, MSc, and Arianna Psichas, PhD from Costello Medical, UK, for management of the Delphi panel, data analysis, medical writing, and editorial assistance based on the authors input and direction
What the Trials Together Do and Do Not Establish Taken together, the three trials make a credible, class-level argument that GLP-1 receptor agonists slow kidney disease progression in people with type 2 diabetes and CKD
Tolhurst, G., et al
Medical guidance is especially important for people who are pregnant, have chronic disease, take multiple medications, or are considering intravenous antioxidant treatments
US$ 29.25
US$ 22.23
US$ 20.83
US$ 20.03
US$ 28.59
US$ 29.01
US$ 22.37
US$ 24.85
US$ 25.39
US$ 22.57
US$ 22.85
US$ 28.33
